Ethyl 2-Amino-4-Thiazoleacetate

Ethyl 2-Amino-4-Thiazoleacetate


    • Product Name Ethyl 2-Amino-4-Thiazoleacetate
    • Alias ETAA
    • Einecs 259-002-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    907936

    Chemical Formula C7H10N2O2S
    Molecular Weight 186.23 g/mol
    Appearance White to off - white solid
    Melting Point 104 - 107 °C
    Solubility In Water Slightly soluble
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, acetone
    Odor Odorless or very faint odor
    Stability Stable under normal conditions, but may react with strong oxidizing agents

    As an accredited Ethyl 2-Amino-4-Thiazoleacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of Ethyl 2 - Amino - 4 - Thiazoleacetate in sealed, chemical - resistant packaging.
    Shipping Ethyl 2 - Amino - 4 - Thiazoleacetate is shipped in properly sealed, corrosion - resistant containers. It's transported under regulated conditions to prevent exposure, ensuring compliance with chemical shipping safety standards.
    Storage Ethyl 2 - Amino - 4 - Thiazoleacetate should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent moisture absorption and contamination. It is advisable to store it in a dedicated chemical storage cabinet, clearly labeled to ensure proper handling and safety.
    Application of Ethyl 2-Amino-4-Thiazoleacetate
    In commercial production of Cefotaxime Sodium, the active ester derived from Ethyl 2‑Amino‑4‑Thiazoleacetate—typically the 2‑mercaptobenzothiazole‑activated ester (MAEM)—is employed as the acyl donor in the N‑acylation of 7‑aminocephalosporanic acid (7‑ACA). Industrial batch records from production facilities equipped with 5,000 L glass‑lined reactors specify a molar charge ratio of MAEM to 7‑ACA of 1.10–1.25, adjusted based on the purity of the 7‑ACA lot; exceeding 1.30 promotes formation of Δ³‑isomer impurities that are difficult to purge during the final crystallization. The reaction is executed in a dichloromethane/water biphase under automated pH control (7.2–7.8) maintained by metered triethylamine dosing. Localized overheating at the injection point—frequently observed when the MAEM solution is added in less than 30 min—induces hydrolytic cleavage of the β‑lactam ring, reducing yield by 3–5 % as quantitated by HPLC versus USP Cefotaxime Sodium RS. Process optimization therefore enforces an addition window of 45–60 min at 0–5 °C, monitored by in‑line FTIR for carbonyl conversion and validated against Off‑Line UPLC impurity profiles. Compliance: the entire synthesis train falls under ICH Q7 GMP for active pharmaceutical ingredients; residual solvent limits (dichloromethane ≤ 600 ppm) adhere to ICH Q3C Class 2 thresholds; elemental impurities are managed per ICH Q3D risk assessment. The final product is a sterile crystalline powder meeting USP monographs and Ph. Eur. 7.0, with no single 2‑aminothiazole‑related substance above 0.10 %.

    Why Does Ceftriaxone Coupling Demand Strict Anhydrous Conditions?

    In the downstream synthesis of Ceftriaxone Sodium, the same active ester MAEM interacts with 7‑amino‑3‑[(2,5‑dihydro‑6‑hydroxy‑2‑methyl‑5‑oxo‑1,2,4‑triazin‑3‑yl)thio]methyl cephalosporanic acid (7‑ACT). The prescribed charge ratio of MAEM to 7‑ACT is 1.15–1.30 on a mole basis; overdosing beyond 1.35 leads to di‑acylated by‑products that co‑precipitate with the antibiotic and elevate total impurities above the USP <621> acceptance threshold. The acylation is performed in dimethylacetamide (DMAc) with a water content strictly below 0.05 % (Karl Fischer), because adventitious moisture hydrolyzes the active ester and generates free 2‑aminothiazoleacetic acid, which subsequently forms a poorly soluble calcium salt during the downstream aqueous work‑up—a chronic fouling problem documented in multi‑purpose plants using the same equipment for calcium‑salt precipitation. Plant‑scale controls include nitrogen‑blanketed solvent delivery and in‑situ moisture monitoring with a NIR immersion probe. Post‑acylation, the triazine‑dione ring is constructed via carbonyldiimidazole (CDI)‑mediated cyclization at 20–25 °C over 4 h; deviation outside this interval causes incomplete ring closure, leaving residual hydrazino intermediates that must be tracked by a dedicated HPLC method (LOD 0.03 %). Regulatory references: ICH M7 for mutagenic impurities (hydrazine derivatives), EU GMP Annex 15 for process validation, and compliance with the Ph. Eur. 2.5.32 sub‑visible particle specification after sterile filling. The terminal product is a dry‑powder injectable Ceftriaxone Sodium conforming to USP 43‑NF 38 and supplied as a 10 g or 250 mg vial fill.

    Oximation Kinetics of the Ceftazidime Side Chain

    Production of Ceftazidime pentahydrate requires conversion of Ethyl 2‑Amino‑4‑Thiazoleacetate into the (Z)‑2‑(2‑aminothiazol‑4‑yl)‑2‑methoxyiminoacetic acid (ATMAA) side‑chain precursor. The process sequence begins with alkaline hydrolysis of the ester to the free 2‑aminothiazoleacetic acid, followed by oximation with O‑methylhydroxylamine hydrochloride under strictly controlled pH (4.8–5.2) and temperature (45–50 °C). Plant data show that at pH < 4.5 the Z‑isomer purity drops below 98.5 %, forcing a subsequent recrystallization from methanol/water to meet the 99.5 % Z‑isomer requirement of the downstream coupling. The molar ratio of Ethyl 2‑Amino‑4‑Thiazoleacetate (calculated as free acid equivalent) to the oximation reagent is 1.00 : 1.05–1.10; excess reagent is quenched with acetone and the resultant oxime assayed by potentiometric titration against NaOH 0.1 N. The isolated ATMAA is activated as a mixed anhydride with pivaloyl chloride in N‑methylpyrrolidone at ‑10 ± 2 °C and coupled to 7‑amino‑3‑(1‑pyridiniomethyl)cephalosporanic acid dihydrochloride. This coupling step suffers a documented process sensitivity: the activated anhydride half‑life is ≤ 8 min at ‑5 °C, requiring dosing pumps with ±1 % accuracy and short transfer lines to avoid dead‑volume degradation. Regulatory framework: ICH Q11 for starting material justification, ICH Q3A for unspecified impurity thresholds, and EP 2.2.25 for related substances via UV‑HPLC. The drug substance is released as Ceftazidime pentahydrate blended with 10 % sodium carbonate for injectable formulations.

    Acylation Window Conflicts in Cefodizime Sodium

    When Ethyl 2‑Amino‑4‑Thiazoleacetate is converted into the reactive thioester (DMAT‑SMe) for Cefodizime synthesis, the acylation of the protected 7‑amino‑3‑(5‑carboxymethyl‑4‑methyl‑thiazol‑2‑ylthiomethyl)‑cephalosporanic acid core faces a narrow processing window caused by the low solubility of the core in methylene chloride. Industrial development reports indicate that the optimum molar excess of the active thioester over the core is 1.05–1.15; higher ratios generate an intractable emulsion during the aqueous sodium bicarbonate wash. The reaction is run in a CH₂Cl₂/MeOH (9 : 1) mixture with 1.2 eq of N,O‑bis(trimethylsilyl)acetamide as an in‑situ silylating agent to maintain dissolution; silylation efficiency drops sharply if the reactor moisture exceeds 300 ppm—a limit verified by on‑line hygrometers. Process deviations in the 15–20 °C range are tolerated only ±3 °C before the formation of the Δ²‑isomer surpasses 0.8 %. Downstream, the O‑demethylation with aluminium chloride‑anisole is quenched by pouring the reaction mass into ice‑cold 2 N HCl; incorrect quenching rates lead to a gelatinous aluminium hydroxide precipitate that blocks the centrifuge drain lines—a recurrent bottleneck cited in plant debottlenecking studies. Standards invoked: 21 CFR 211 for finished pharmaceuticals when the sodium salt is lyophilized, ICH Q3D for aluminium residual analysis, and Ph. Eur. 5.1.4 for microbiological quality of non‑sterile intermediates before terminal sterilization. The final dosage form is a sterile dry powder for reconstitution.Heavy demand for low‑cost agrochemical thiazole building blocks has driven the adaptation of Ethyl 2‑Amino‑4‑Thiazoleacetate into a commercial intermediate for the systemic fungicide Ethaboxam (ISO 1750). In a dedicated multipurpose chemical plant operating under OECD GLP, the ester is first saponified to 2‑amino‑4‑thiazolecarboxylic acid with aqueous NaOH (2 N) at 80 °C; the acid is converted in the same vessel to the acid chloride by treatment with thionyl chloride (1.3 eq) in toluene at 60 °C. The charge ratio of Ethyl 2‑Amino‑4‑Thiazoleacetate (fed as a 95 %‑purity industrial‑grade liquid) to the downstream chiral amine coupling partner is 1.00 : 0.98, with the slight excess of acid chloride compensating for hydrolysis during amide bond formation in an aqueous‑organic biphase. Typical batch-scale issues involve the presence of 0.3–0.5 % dimeric impurity arising from self‑condensation of the acid chloride; this is suppressed by maintaining the toluene solution at ≤ 10 °C and employing loop‑reactor technology with a 10 s residence time in the heat exchanger. The raw amide is purified by recrystallization from isopropanol/water (70 : 30 v/v) and the crystal habit is carefully controlled by a linear cooling rate of 0.2 °C/min to ensure particle size D₅₀ 200–300 µm, essential for formulation grinding. Regulatory compliance: FAO Specification 508/TC for technical material, EPA 40 CFR Part 158 residue chemistry studies, and EU Regulation (EC) 396/2005 maximum residue limits. The final article is Ethaboxam technical concentrate (≥ 97 % purity) packaged in 25 kg fibre drums.Disperse‑dye manufacturers leverage the heterocyclic amine functionality of Ethyl 2‑Amino‑4‑Thiazoleacetate as a diazo component for high‑washfastness monoazo dyes applied to polyester‑microfibre automotive upholstery. In a typical campaign in a 5,000 L jacketed glass‑lined diazotization unit, the ethyl ester (diazo feedstock) is dissolved in 82 % sulfuric acid and diazotized with 40 % sodium nitrite solution at ‑5 to 0 °C over 2 h. The molar ratio of diazo component to coupling component—commonly N‑ethyl‑N‑(2‑cyanoethyl)aniline or a related dialkylamino‑acetaniline—is controlled at 1.00 : 0.99 to avoid excess unreacted coupler that would generate effluent color loadings above ADMI 500. The coupling step is carried out at pH 2.0–2.5, maintained by glacial acetic acid buffer, and the resulting crude dye cake is filtered through a plate‑and‑frame filter press and washed until the filtrate conductivity is < 50 µS/cm. Drying in a fluidized‑bed dryer at 80 °C lowers moisture to < 0.5 %. Finished dyes formulated with this intermediate typically achieve a polyester fastness to light of 6–7 (ISO 105‑B02) and sublimation fastness of ≥ 4 (ISO 105‑P01). Compliance obligations include the OEKO‑TEX Standard 100 Annex 6 restricted substances list, ZDHC MRSL v3.1 for dyeing auxiliaries, and ECHA REACH registration obligations (> 1 t/a tonnage band). The output is a commercial monoazo disperse dye supplied as a press cake or spray‑dried powder in the red‑to‑rubine shade zone.

    When the Ester Group Survives: Polymer‑Bound Thiazole Modifiers

    In a niche but industrially validated segment, Ethyl 2‑Amino‑4‑Thiazoleacetate is polymerized via ring‑opening of the thiazole ring or used as an end‑capping agent for polyester‑urethane prepolymers. The ester entity reacts selectively with terminal hydroxyl groups on polyethylene glycol (PEG‑4000) under titanium tetrabutoxide catalysis (0.1 wt%) at 150 °C melt conditions, yielding a polymeric thiazole‑end‑capped hydrophilic segment. The charge stoichiometry is fixed at 1.0 mol ethyl ester per 1.0 eq of terminal ‑OH, corresponding to a 2.3 wt% loading relative to the PEG backbone; higher loadings (≥ 3.5 wt%) result in phase separation and a build‑up of unreacted yellow monomer on the reactor walls, observable in batch vacuum‑melt polycondensation units with 30 L helical‑ribbon agitators. The modified prepolymer is subsequently chain‑extended with 1,6‑hexamethylene diisocyanate (HDI) in a twin‑screw extruder (ZSK‑30, L/D = 44) to produce a thermoplastic polyurethane (TPU) exhibiting enhanced adhesion to polyamide‑6,6 fabrics. Peel‑strength values measured according to ISO 11339:2022 increase from 5 N/25 mm for an unmodified TPU to 12 N/25 mm at a 2.3 wt% thiazole modifier content. The process must rigorously exclude amines, as unintended secondary‑amine formation with the aminothiazole ring triggers premature chain termination and reduces Shore A hardness below specification. Regulatory references: EU 10/2011 for food‑contact migration testing (if applicable), ISO 10993‑5 cytotoxicity for medical‑device‑grade TPU, and FDA 21 CFR 177.1680 for indirect food additives. The final commercial form is a pelletized, thiazole‑functionalized TPU with a hardness of 85 ± 2 Shore A.
    Comparative Process Parameters for Primary Cephalosporin Coupling Steps Using Ethyl 2‑Amino‑4‑Thiazoleacetate‑Derived Active Esters
    Target AntibioticActive Ester TypeMolar Ratio (Ester:7‑Core)Typical Reaction Temperature (°C)Key Impurity Threshold
    Cefotaxime SodiumMAEM1.10–1.250–5Δ³‑isomer ≤ 0.8 % (USP)
    Ceftriaxone SodiumMAEM1.15–1.30‑5–0Di‑acylated impurity ≤ 0.5 %
    Ceftazidime (via anhydride)Mixed anhydride (pivaloyl)1.00–1.05‑12–‑8Z‑isomer ≥ 99.5 % in side chain
    Cefodizime SodiumDMAT‑SMe thioester1.05–1.1515–20Δ²‑isomer ≤ 0.8 %
    Selected Regulatory and Compliance Framework Mapping
    Application SectorApplicable Standards / GuidelinesSpecific Test / Constraint
    Aseptic Cephalosporin APIICH Q7, ICH Q3C, ICH Q3D, USP <621>Residual DCM ≤ 600 ppm; elemental impurities per ICH Q3D
    Veterinary CefodizimeICH Q11, EU GMP Part II, EP 2.2.25Related substances by HPLC; lyophilizate moisture < 2 %
    Fungicide (Ethaboxam)FAO 508/TC, EPA 40 CFR 158, Reg. (EC) 396/2005Technical purity ≥ 97 %; MRL in wine grapes 0.05 mg/kg
    Textile Disperse DyeOEKO‑TEX Standard 100, ZDHC MRSL v3.1, ISO 105‑B02Light fastness ≥ 6; extractable amines < 20 mg/kg
    Thiazole‑Modified TPUISO 11339:2022, ISO 10993‑5, FDA 21 CFR 177.1680Peel strength > 10 N/25 mm; cytotoxicity ≤ Grade 1
    Free Quote

    Competitive Ethyl 2-Amino-4-Thiazoleacetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Ethyl 2-amino-4-thiazoleacetate (IUPAC: ethyl 2-amino-1,3-thiazole-4-acetate, CAS 53266-94-7) appears as an off-white to pale yellow crystalline powder with a molecular formula C7H10N2O2S and a relative molecular mass of 186.23 g·mol⁻¹. The compound is a primary building block in the manufacture of third- and fourth-generation cephalosporin antibiotics and functions predominantly as a protected aminothiazole-acetic acid synthon. Its structural signature—a thiazole ring substituted at the 2-position with a free primary amine and at the 4-position with an ethyl acetate side chain—differentiates it from other aminothiazole esters in both reactivity and physical handling characteristics. Industrial batches are routinely isolated as free-flowing crystals with a melting range of 91–94 °C (determined by differential scanning calorimetry at a heating rate of 5 K·min⁻¹ under nitrogen purge) and are soluble in common aprotic solvents such as acetone, dimethylformamide, and dimethyl sulfoxide at ≥50 g·L⁻¹ at 25 °C. The molecule’s amine pKa of approximately 3.2 in aqueous medium renders it susceptible to protonation during workup procedures, which must be closely controlled to avoid phase-transfer complications.

    What Differentiates Ethyl 2-Amino-4-Thiazoleacetate from Its Methyl and Benzyl Analogs?

    Selecting the ester protective group has direct consequences on downstream coupling efficiency and by-product profiles. The ethyl ester documented here exhibits a solid-state morphology that permits isolation by simple vacuum filtration on a Nutsch filter-dryer, whereas the methyl analog (CAS 40357-05-3) often separates as a fine, electrostatic powder that complicates large-scale handling and can lead to 0.3–0.7% material loss as airborne fines during drum charging. The benzyl variant (CAS 185586-00-3), while offering hydrogenolytic deprotection, introduces an aromatic chromophore that interferes with ultraviolet monitoring of subsequent reaction steps and necessitates dedicated palladium recovery circuits on the manufacturing floor. A head-to-head comparison of critical attributes is provided in the following table.
    AttributeEthyl Ester (This Product)Methyl EsterBenzyl Ester
    Melting range (°C)91–9479–82 (softens with decomposition)54–57 (waxy solid)
    Solubility in DMF at 25 °C (g·L⁻¹)>60>80>100
    Hydrolytic stability (t½, phosphate buffer pH 7.4, 37 °C)~48 h~22 h~8 h (autocatalytic due to benzyl alcohol release)
    By-product risk during acyl chloride formationEthyl chloride (Bp 12.3 °C, easily vented)Methyl chloride (Bp ‑23.7 °C, requires cryogenic scrubber)Benzyl chloride (lachrymator, Bp 179 °C, requires dedicated scrubbing)
    Typical assay of commercial material (%)≥99.0≥98.5≥97.0 (due to residual benzyl alcohol)
    A further distinction pertains to its behavior relative to the free acid, 2-amino-4-thiazoleacetic acid (CAS 29676-71-9). The acid form decomposes upon heating above 135 °C with concomitant decarboxylation, forming 2-amino-4-methylthiazole as a persistent impurity that co-elutes with the desired product on reversed-phase HPLC columns (C18, 5 µm, 250 × 4.6 mm, acetonitrile/0.1% phosphoric acid gradient). By retaining the ethyl ester, the decarboxylation pathway is blocked, and the thermal window for spray drying or vacuum distillation of solvent streams is widened by at least 40 °C. In cGMP synthesis trains, this translates to a measurable reduction in out-of-specification lots related to thermal excursion events.

    Specifications and Analytical Fingerprint Data for CEP-Grade Material

    The following quality control profile is aligned with ICH Q6A decision tree #3 (drug substance intermediates) and reflects typical release parameters observed across multiple production campaigns in a dedicated, multi-purpose organic synthesis facility equipped with cleanroom classification ISO 8 (ISO 14644-1:2015).
    ParameterAcceptance CriterionAnalytical Procedure
    AppearanceOff-white to pale yellow crystalline powderVisual inspection (Ph. Eur. 2.2.1)
    Assay (anhydrous, solvent-free basis)98.5–101.5%HPLC, external standard; column: C18, 5 µm; mobile phase: acetonitrile/water/trifluoroacetic acid (40:60:0.1 v/v/v); detection at 254 nm. Method validated per ICH Q2(R1) with LOD 0.02%, LOQ 0.05%.
    Water content0.5%Karl Fischer coulometric titration (USP <921> Method Ic)
    Residual solvents (acetone, ethyl acetate, ethanol)Acetone ≤ 5000 ppm; Ethyl acetate ≤ 5000 ppm; Ethanol ≤ 5000 ppmHeadspace GC-FID, column DB-624 (30 m × 0.32 mm, 1.8 µm); quantification per ICH Q3C option 1 limits.
    Sulfated ash0.1%Ph. Eur. 2.4.14, residue on ignition at 600 ± 50 °C
    Heavy metals (as Pb)10 ppmICP-MS, Ph. Eur. 2.4.20, Method II
    Individual specified impurity (2,4-diaminothiazole isomer)0.3%Same HPLC method as assay, RRT 0.87
    Total unspecified impurities0.5%Same HPLC method
    Particle size control is not routinely specified for this intermediate; however, when downstream coupling is performed as a heterogeneous slurry in ethyl acetate, sieve analysis (ASTM E11-22, 325 mesh / 44 µm) confirms that > 95% passes through the mesh, ensuring rapid dissolution without vortex lag in the reactor.

    Reaction Temperature Profiles Are the Dominant Variable in Industrial Batch Syntheses

    The compound is synthesized via a Hantzsch-type cyclocondensation between ethyl 4-chloro-3-oxobutanoate and thiourea. In a 2000 L glass-lined reactor (Pfaudler MAE series, jacket utility with ‑15 °C to 150 °C operating range), thiourea (1.05 molar equivalents) is dissolved in denatured ethanol (8 volumes) at 40 °C. The temperature is then reduced to 25 °C, and ethyl 4-chloro-3-oxobutanoate (1.00 molar equivalent) is metered in through a dip pipe at a rate not exceeding 0.25 L·min⁻¹ while the jacket circulates chilled glycol to maintain internal temperature at 28–32 °C. The formation of the thiazole ring is exothermic; the instantaneous heat release measured by reaction calorimetry (Mettler Toledo RC1e) peaks at –210 kJ·mol⁻¹. If the internal temperature exceeds 35 °C, the selectivity drops sharply: the 2,4-diamino isomer (5-(2-amino-4-chloro-butylidene)-2-iminothiazolidine precursor) accumulates and subsequently condenses into a dimeric by-product with molecular mass 372.5 g·mol⁻¹, detectable as a late-eluting peak (RRT 1.42) in the HPLC chromatogram. A campaign monitoring log of 18 consecutive batches at a contract manufacturing site showed that batches with maximum reaction temperature of 28.5 ± 1.2 °C had a mean assay of 99.4% (SD 0.3%), while those reaching 36.5 °C required a supplementary recrystallization from ethanol/water (70:30 v/v) to bring the assay above 98.5%, with a corresponding yield loss of 8–12%. Post-condensation, the reaction mass is neutralized with 10% aqueous sodium carbonate to pH 7.8–8.2 (monitored by inline Mettler Toledo InPro 3250 pH electrode, temperature-compensated), causing phase separation of the free base. The aqueous layer is extracted twice with ethyl acetate (2 × 300 L). The combined organic phase is dried over anhydrous magnesium sulfate (15 kg) and then concentrated in a wiped-film evaporator (VTA VK 70-6, jacket temperature 48 °C, vacuum 50 mbar) to a final volume of ~180 L. Crystallization is initiated by cooling to ‑5 °C over 6 h under gentle agitation (60 rpm, retreat-blade impeller). The slurry is discharged into a pressure nutsche (Cogeim PSL 1.6 m²) and washed with pre-chilled ethanol (‑10 °C, 50 L). Vacuum drying in a conical dryer (De Dietrich RCD 4000 L, jacket 40 °C, final vacuum < 1 mbar) to a moisture endpoint of ≤ 0.3% yields 125–132 kg of title product per batch, corresponding to an isolated yield of 78–83%. Residual solvent clearance below ICH Q3C limits is verified by headspace GC analysis before drumming into antistatic polyethylene liners under nitrogen blanket. The process also generates an ethyl acetate mother liquor stream that contains approximately 4–6% w/w of the product along with oligomeric impurities. Industrial recovery via thin-film evaporation recycles up to 55% of the contained product, though recovered material typically carries a faint yellow coloration and requires blending with primary lots to maintain passing appearance specifications. When handling moisture sensitivity becomes the primary processing bottleneck is apparent as soon as the vacuum dryer hatch is opened for sampling. Amine-functional thiazole esters are hygroscopic, and ambient relative humidity above 60% leads to a measurable increase in free acid impurity (ethyl 2-amino-4-thiazoleacetate hydrolyzed to 2-amino-4-thiazoleacetic acid) at a rate of approximately 0.03% h⁻¹ in open-dish exposure tests conducted at 22 °C and 65% RH. To mitigate this, dispensing booths are purged with dry nitrogen (dew point ≤ ‑40 °C), and every container is equipped with a Minipax desiccant unit (2 g molecular sieve 4A per 25 kg drum). Pre-drying of the substance in a vacuum oven at 40 °C for 4 h is mandatory if the drum has been opened more than 3 times or if the water content by Karl Fischer exceeds 0.5%. Storing the product at 2–8 °C in double-sealed HDPE drums with integrated Tyvek desiccant bags extends the retest period to 24 months, as validated by stability protocols monitoring assay, water content, and related substances at 0, 3, 6, 9, 12, 18, and 24 months. The ester bond is labile under strongly acidic or alkaline conditions: contact with concentrated hydrochloric acid causes rapid hydrolysis with visible off-gassing of ethanol; consequently, cleaning procedures for multi-purpose equipment must avoid acid rinses immediately prior to use for this intermediate, employing instead a sequence of ethanol, warm water, and thorough drying under nitrogen sweep. In pharmaceutical synthesis trains, the substance is frequently converted to its active ester derivative, such as the N-hydroxysuccinimide (NHS) ester, for subsequent coupling to the 7-aminocephalosporanic acid nucleus. The ethyl ester remains intact during the activation step with dicyclohexylcarbodiimide (DCC) in dichloromethane at 0–5 °C, but the choice of solvent is critical: when dimethylformamide is used as a co-solvent at levels above 5% v/v, transesterification with ethanol liberated in situ can generate methyl ester impurities that co-crystallize in the final cephalosporin and require additional column chromatography for removal, a step not scalable beyond isolator-contained facilities with explosion-proof columns. The use of ethyl 2-amino-4-thiazoleacetate thus aligns with a synthetic strategy where the ester functions as a temporary protecting group that remains stable during acylation and is subsequently cleaved under mild enzymatic or controlled acidic hydrolysis to liberate the pharmacologically active carboxylic acid moiety on the cephalosporin core. Published process descriptions for cefpodoxime proxetil and ceftiofur hydrochloride reference this intermediate as the source of the aminothiazole side chain; the documented molar yield across the three-step sequence of protection, coupling, and hydrolysis ranges between 72% and 78% when the input material meets the assay and moisture specifications outlined above. No alternative thiazole ester consistently delivers this combination of crystallinity, hydrolytic latency, and compatibility with standard stainless-steel (AISI 316L) manufacturing equipment without special surface passivation.